Talking Point is a regular series of publicly available lectures that aim to inspire, inform and challenge our notions of what we know about addiction and its impact across society. Health and social sector professionals and the general public are all welcome to attend. Can we really change behaviour at a population level? The Communities
This webinar will give an overview of substance-related psychosis and is part of the University of Sydney’s Matilda Centre for Research in Mental Health and Substance Use Comorbidity Project webinar series, which is focused on applying evidence into practice his webinar will take place on Tuesday 12th of August 10am-11am AEST This webinar will be
Connect & Learn Webinar Friday 8th August 2025 - online from 1pm to 1:45pm Identifying and supporting clients with cognitive impairment, presented by Georgia Bolt This webinar is only available to staff who are working in a Victorian Department of Health (DH) funded AOD organisation. This presentation situates cognitive impairment as a key factor to
Talking Point: Addressing Underlying Trauma in Opioid Use. Thursday 7th August 2025, 1pm - 2pm AEST - ONLINE Up to 90% of people with opioid use disorder (OUD) have trauma exposure and up to 41% have posttraumatic stress disorder (PTSD). However, studies estimate that less than 12% of people with OUD and co-occurring PTSD receive
Talking Point - Wednesday 30th July 2025, 1pm - 2pm AEST - ONLINE Using Law to Reduce the Cancer Burden of Alcohol, presented by Clare Slattery, Legal Policy Advisor at the McCabe Centre for Law and Cancer Alcohol use is linked to more than 200 diseases, injuries and other health conditions, including cancer. Law is
An introduction to AOD peer work including misconceptions, challenges, benefits and best practice, presented by Benn Veenker Tuesday 22 July 2025 - online from 1pm to 1:45pm This presentation will start with unpacking exactly what is lived and living experience and what does this mean within an AOD context. There will be a deeper dive
Talking Point - Wednesday 25th June 2025, 1pm to 2pm AEST - ONLINE Lisdexamfetamine in the treatment of methamphetamine dependence, presented by Dr Nadine Ezard. We conducted a randomised double-blind placebo controlled trial of 250mg lisdexamfetamine daily vs placebo among 164 adults with methamphetamine dependence at 6 outpatient services around Australia. The study was impacted by
Webinar Join us during National Reconciliation Week 2025 for a free webinar hosted by Windana’s First Peoples’ Healing Program team with DDACL. If you work in Victoria’s Health Care and Social Assistance sectors, this will be a valuable session for raising awareness of culturally connected services available. Based on the land of the Bunurong People,
